KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Investment Income: 2009

Historic Investment Income for Alnylam Pharmaceuticals (ALNY) over the last 1 years, with Dec 2009 value amounting to -$4,000.

  • Alnylam Pharmaceuticals' Investment Income was N/A to -$4,000 in Q4 2009 from the same period last year, while for Dec 2009 it was -$215,696, marking a year-over-year change of. This contributed to the annual value of -$121,000 for FY2009, which is N/A change from last year.
  • As of Q4 2009, Alnylam Pharmaceuticals' Investment Income stood at -$4,000, which was down 0.00% from -$4,000 recorded in Q3 2009.
  • Alnylam Pharmaceuticals' 5-year Investment Income high stood at -$4,000 for Q3 2009, and its period low was -$117,696 during Q1 2009.
  • Over the past 1 years, Alnylam Pharmaceuticals' median Investment Income value was -$47,000 (recorded in 2009), while the average stood at -$53,924.